IL33 and asthma: We have previously discovered common sequence variants in IL33 and it’s receptor IL1RL1 conferring risk of asthma8, followed by an identification of a rare loss of function variant in IL33 that protects against asthma9, thereby supporting its relevance as pharmacological target for asthma.